Eric Lefkofsky looks to disentangle vast layers of oncological data

Everything from patient medical histories to the ways different groups of people react to a particular drug are all recorded millions of times every hour in the United States alone. The problem is not a lack of data, the problem is data overload and learn more about Eric.

Luckily, a number of solutions to the problem of data overload have been coming online over the last few decades. Artificial intelligence is one of the most effective ways in which vast quantities of data have been able to be converted into actionable intelligence in many different fields. However, medicine-specific AI solutions that help doctors make sense of the ocean of data that medical professionals swim in every day have been slow to come to market.

Now, Eric Lefkofsky, the founder of volume discount giant Groupon, is tackling this problem, head on. Through his new startup, Tempus, he is seeking to do nothing short of revolutionizing the way in which physicians look at data and make treatment decisions on behalf of their patients and more information click here.

One of the main problems that fields like oncology currently face is the huge variance in patient outcomes that is not well explained by the treatment regimen alone. In other words, there is a great deal of randomness involved in how one patient with, say breast cancer, does versus another. What’s often so tragic is that, often times, oncologists know that these differences are not actually random, they just appear to be. The reason this random variance in treatment outcomes appears is because oncologists don’t understand the relationships between data points. People are literally dying because oncological analytics are lacking and its Website.

The systems he is creating will be able to give physicians the powerful results of studies that would otherwise have taken months and cost millions of dollars, all at the click of a button. Tempus is effectively creating solutions that will allow physicians to get accurate, on-the-spot answers to incredibly complex problems, such as how a patient with a certain race, blood type and smoking history is likely to respond to a treatment and Eric’s lacrosse camp.

More visit:

One Reply to “Eric Lefkofsky looks to disentangle vast layers of oncological data”

  1. Through Tempus, Eric Lefkofksy is starting to change that. Current drug produces tremendous troves of information. That is the way in which bestessay review can do all of these things and it helps a lot which is really great.

Comments are closed.